A- A A+

Peter Mu-Hsin Chang (張牧新)

  • 2875-7270
Peter Mu-Hsin Chang(張牧新)

簡介

學歷
  1. 國立陽明大學 臨床醫學研究所 博士
  2. 國立成功大學 醫學系 醫學士
經歷 現職:
  1. - 迄今 臺北榮民總醫院 腫瘤醫學部 藥物治療科 主治醫師
  2. - 迄今 國立陽明大學 醫學系 內科學科 部定副教授
經歷:
  1. - 臺北榮民總醫院 內科部 血液腫瘤科 主治醫師
  2. - 臺北榮民總醫院 內科部 住院醫師
  3. - 國立陽明大學 醫學系 講師
  4. - 史丹佛大學 Department of Chemical and Systems Biology 訪問學者
醫療專長
  1. 一般腫瘤內科學、頭頸癌、鼻咽癌、泌尿系統癌症、臨床試驗、新藥開發
證照
  1. 內科專科醫師、腫瘤科專科醫師、安寧緩和專科醫師、頭頸部腫瘤醫學專科醫師

著作

PubMed

  1. Chang PM, Chen CH, Yeh CC, Lu HJ, Liu TT, Chen MH, Liu CY, Wu ATH, Yang MH, Tai SK, Mochly-Rosen D*, Huang CF*.  Transcriptome Analysis and Prognosis of ALDH Isoforms in Human Cancer. Sci Rep 2018 Feb; 8(1): 2713. (IF: 4.259; Multidisciplinary Sciences 10/64)

  2. Chang PM, Lu HJ, Wang LW, Tai SK, Chen MH, Chu PY*, Yang MH*.  Effectiveness of Incorporating Cetuximab into Docetaxel/Cisplatin/Fluorouracil Induction Chemotherapy and Chemoradiotherapy for Inoperable Squamous Cell Carcinoma of the Oral Cavity: A Phase II Study. Head Neck 2017 Jul; 39(7): 1333-42. Epub 2017 Apr. (IF: 3.376; Otorhinolaryngology 1/42; Surgery 34/196)

  3. Lu HJ, Mu-Hsin Chang P*.  How to Treat Recurrent/Metastatic Head and Neck Cancer: the Economic Issue in Real-World Practice. Curr Med Res Opin 2017 Apr; 33(4): 779-80. Epub 2017 Jan. (IF: 2.757; Medicine, General & Internal 33/154; Medicine, Research & Experimental 53/128)

  4. Lu HJ, Yang CC, Wang LW, Chu PY, Tai SK, Chen MH, Yang MH, Chang PM.  Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer. Biomed Res Int 2015 Feb; 2015(): 307576. (IF: 2.134; Biotechnology & Applied Microbiology 82/161; Medicine, Research & Experimental 72/124)

  5. Chen WC, Chu PY, Lee YT, Lu WB, Liu CY, Chang PM*, Yang MH*.  Pembrolizumab for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in an Asian Population. Medicine (Baltimore) 2017 Dec; 96(52): e9519. (IF: 1.803; Medicine, General & Internal 58/154)

  6. Chang PM, Cheng CT, Wu RC, Chung YH, Chiang KC, Yeh TS, Liu CY, Chen MH, Chen MH*, Yeh CN*.  Nab-Paclitaxel is Effective against Intrahepatic Cholangiocarcinoma via Disruption of Desmoplastic Stroma. Oncol Lett 2018 Jul; 16(1): 566-72. Epub 2018 May. (IF: 1.664; Oncology 193/222)